Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis
Takashi Muraki(Emory University), Volkan Adsay(Koç University), Juan M. Sarmiento(Emory University), Shishir K. Maithel(Broad Institute), Kee‐Taek Jang(Samsung Medical Center), David A. Kooby(Emory University), Michelle D. Reid(Emory University), Susan Tsai(The Ohio State University Wexner Medical Center), Bahar Memiş(Kocaeli Üniversitesi), Kathleen K. Christians(Medical College of Wisconsin), Douglas B. Evans(The University of Texas MD Anderson Cancer Center), Olca Baştürk(Memorial Sloan Kettering Cancer Center), Burçin Pehlivanoğlu(Dokuz Eylül University), Pardeep Mittal(Emory University)
Cited by 31
Related Papers
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
|Nature|2017|1.2k
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
|BMC Cancer|2018|391
Population-Based Study of Islet Cell Carcinoma
|Annals of Surgical Oncology|2007|338